Managing Acute Kidney Injury in Severe Falciparum Malaria: Insights from a Challenging Case
Abstract
Malaria continues to pose a significant public health challenge, particularly in certain regions of Indonesia, where it remains endemic. Plasmodium falciparum is responsible for the most severe form of the disease, often leading to life-threatening complications such as acute kidney injury (AKI). Here, we report the case of a 22-year-old male from Sikka Regency, East Nusa Tenggara, Indonesia, with a seven-day history of intermittent fever following recent travel to malaria-endemic areas. On physical examination, he appeared somnolent and exhibited icteric sclera, hepatomegaly, and dark yellow urine. Laboratory findings were notable for impaired kidney function (serum creatinine 3.52 mg/dL (311 μmol/L)), elevated transaminases, hyperbilirubinemia, thrombocytopenia, and a P. falciparum parasitemia level of 9.7%. Imaging studies revealed pulmonary edema, enlarged kidneys, ascites, pleural effusion, and hepatomegaly. The patient was diagnosed with severe falciparum malaria, complicated by AKI, pulmonary edema, and jaundice. He was then treated with intravenous artesunate for six days, followed by a three-day course of oral dihydroartemisinin/piperaquine and a single dose of primaquine. Additionally, he underwent two sessions of timely hemodialysis. His clinical condition and kidney function gradually improved thereafter, and he was discharged without sequelae. This case highlights that early diagnosis and appropriate treatment can lead to full recovery from AKI caused by severe P. falciparum malaria.
2. Directorate General for Disease Prevention and Control, Ministry of Health RI. Annual malaria report 2022. Jakarta: Ministry of Health RI; 2023.
3. World Health Organization. WHO guidelines for malaria. Geneva: World Health Organization; 2024. Available from: https://www.who.int/publications/i/item/guidelines-for-malaria
4. Plewes K, Turner GDH, Dondorp AM. Pathophysiology, clinical presentation, and treatment of coma and acute kidney injury complicating falciparum malaria. Curr Opin Infect Dis. 2018;31(1):69-77.
5. Trang TT, Phu NH, Vinh H, et al. Acute renal failure in patients with severe falciparum malaria. Clin Infect Dis. 1992;15(5):874-80.
6. Brown DD, Solomon S, Lerner D, et al. Malaria and acute kidney injury. Pediatr Nephrol. 2020;35(4):603-608.
7. Mohapatra MK, Behera AK, Karua PC, et al. Urinary bile casts in bile cast nephropathy secondary to severe falciparum malaria. Clin Kidney J. 2016;9(4):644-8.
8. Das BK, Barman H, Hazarika RD, et al. Management of hyperparasitaemia in severe malaria: a sea change with the availability of artesunate. Cureus. 2024;16(3):e56894.
9. Sinclair D, Donegan S, Isba R, et al. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev. 2012; 2012(6):CD005967.
10. World Health Organization. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; 2015. Available from: https://www.afro.who.int/publications/guidelines-treatment-malaria-third-edition
11. Stepniewska K, Humphreys GS, Gonçalves BP, et al. Efficacy of single-dose primaquine with artemisinin combination therapy on Plasmodium falciparum gametocytes and transmission: an individual patient meta-analysis. J Infect Dis. 2022; 225(7):1215-1226.
12. Hanson J, Anstey NM, Bihari D, et al. The fluid management of adults with severe malaria. Crit Care. 2014;18(6):642.
13. Silva GBD Junior, Pinto JR, Barros EJG, et al. Kidney involvement in malaria: an update. Rev Inst Med Trop Sao Paulo. 2017;59:e53.
14. Palevsky PM. Renal replacement therapy in acute kidney injury. Adv Chronic Kidney Dis. 2013;20(1):76-84.
15. World Health Organization. Severe malaria. Trop Med Int Health. 2014;19 Suppl 1:7-131.
Files | ||
Issue | Vol 20 No 2 (2025) | |
Section | Case Report(s) | |
Keywords | ||
Severe falciparum malaria Acute kidney injury Artesunate Hemodialysis |
Rights and permissions | |
![]() |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |